We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine.
We have initiated a new safety review into topiramate as a result of an observational study reporting an increased risk of neurodevelopmental disabilities in children whose mothers took topiramate during pregnancy. Topir…
Collection of information and guidance for patients and for healthcare professionals on the reproductive risks of valproate and new safety measures introduced to reduce these risks.
List of Field Safety Notices from 20 to 24 May 2024.
Safety leaflet to help you understand the latest information about the effects of pregabalin during pregnancy.
The MHRA continues to receive reports of deaths and serious injuries from entrapment or falls relating to medical beds, bed rails, trolleys, bariatric beds, lateral turning devices and bed grab handles.
You must get permission to export certain drugs and medicines.
Advice for manufacturers of Class I medical devices for placing products on the UK market
New simplified guidance on treating paracetamol overdose with intravenous acetylcysteine including an updated treatment nomogram.
How to apply for a traditional herbal registration (THR) to market a herbal medicine in the UK.
Department of Health and Social Care and MHRA register of licensed wholesale distribution sites (human and veterinary).
Advice for healthcare professionals regarding the withdrawal of pholcodine-containing medicines from the market.
How to conform with the legal requirements for placing medical devices on the market.
Information on when software applications are considered to be a medical device and how they are regulated.
Advice for healthcare professionals on the reclassification of codeine linctus to a prescription-only medicine (POM), following a public consultation.
The MHRA is asking organisations to put a plan in place to implement new regulatory measures for sodium valproate, valproic acid and valproate semisodium (valproate). This follows a comprehensive review of safety data, advic…
Batch Number 1K10121 has been found to potentially have the wrong amount of active ingredients
No evidence of supply or harm to patients
MHRA highlight the pitfalls of buying medicines online to students
We have strengthened the safe use of isotretinoin through the introduction of additional oversight of the initiation of isotretinoin in patients under 18 years and through improved assessment and monitoring of mental health …
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).